We are live on ! Find out more
KBIO

KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO

Delisted

KBIO was delisted on the 16th of December, 2015.

Back to rankings

Fund managers haven’t disclosed any holdings of KBIO yet.

KBIO Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q3 2016, worth a combined $66K.

Buyers outnumbered sellers: 1 fund opened new KBIO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Gerstein Fisher, opening a new position worth an estimated $66K.

  • 1 institutional investor held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $66K of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q3 2016.
  • 1 fund opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) buyer in Q3 2016 was Gerstein Fisher, an estimated $66K added.

Based on aggregated 13F filings for Q3 2016.